ID: ALA5278551

Max Phase: Preclinical

Molecular Formula: C20H20O6

Molecular Weight: 356.37

Associated Items:

Representations

Canonical SMILES:  COc1cc(OCC=C(C)C)c2c(=O)c3c(O)ccc(OC)c3oc2c1

Standard InChI:  InChI=1S/C20H20O6/c1-11(2)7-8-25-15-9-12(23-3)10-16-18(15)19(22)17-13(21)5-6-14(24-4)20(17)26-16/h5-7,9-10,21H,8H2,1-4H3

Standard InChI Key:  JOGYBYIYJAVPLQ-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.37Molecular Weight (Monoisotopic): 356.1260AlogP: 4.01#Rotatable Bonds: 5
Polar Surface Area: 78.13Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.86CX Basic pKa: CX LogP: 4.19CX LogD: 4.18
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.55Np Likeness Score: 1.43

References

1. Santos CMM, Freitas M, Fernandes E..  (2018)  A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.,  157  [PMID:30282319] [10.1016/j.ejmech.2018.07.073]

Source